OpenAlex
PricingAboutJobs
Log inGet started
Work

Effect of sitagliptin, a dipeptidyl peptidase‐4 inhibitor, on beta‐cell function in patients with type 2 diabetes: a model‐based approach

HTML

Year: 2008
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2008.00887.x
Authors: L. Xu, C. Dalla Man, B. Charbonnel, G. Meninger, M. J. Davies, D. Williams‐Herman, C. Cobelli, P. P. Stein
Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), University of Padua, Centre Hospitalier Universitaire de Nantes
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: sitagliptin, DPP-4 inhibitors, type 2 diabetes, beta-cell function, insulin secretion rate, insulin sensitivity, disposition index, postprandial blood glucose, metformin, pharmacodynamic modeling, meal tolerance test, basal insulin secretion
SDG: Good health and well-being

Open Access status: closed

Funders: Amylin Pharmaceuticals, Novartis
OpenAlex ID: W1968236091
FWCI: 6.477
Cites: 23
Cited by: 96
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security